Research-Backed Technology.
Medical-Grade Manufacturing.
The lower-limb exoskeleton systems GaitExo supplies are built on serious rehabilitation engineering foundations -- not consumer robotics. This page explains the technology behind the devices, how they are manufactured, and how they are deployed clinically.
- Gait recognition and human-robot interaction research with Chinese Academy of Sciences partners
- ISO 13485 quality management across all manufacturing partners
- Active clinical deployment in Chinese neuro-rehabilitation hospitals and rehabilitation centers
Human-Robot Integration for
Safe Gait Assistance
Effective gait exoskeleton design requires the device to sense, interpret, and respond to the user's movement intentions in real time -- not just execute pre-programmed patterns.
Gait Phase Recognition
Onboard sensors continuously detect which phase of the gait cycle the user is in -- stance, swing initiation, mid-swing, or terminal swing -- and adjust joint assistance timing accordingly. This enables natural, responsive movement rather than rigid robotic motion.
Adaptive Assistance Levels
Therapists can adjust the level of motor assistance provided at each joint, allowing the device to support patients across a range of ability levels -- from complete dependence in early rehabilitation to minimal assistance as the patient progresses.
Real-Time Safety Monitoring
Built-in safety algorithms continuously monitor joint angles, forces, and patient posture. The system limits joint range of motion to clinically safe parameters and triggers automatic pause if unexpected movement patterns are detected.
Multi-Sensor Feedback and
Intelligent Control
Each device integrates multiple sensor types to create a continuous feedback loop between the patient, the exoskeleton, and the control system -- enabling responsive, safe, and therapeutically effective assistance.
Sensor Layer
- Inertial measurement units (IMUs) at each major joint segment for real-time orientation and acceleration data
- Force/torque sensors at foot contact points for ground reaction force detection
- Joint angle encoders providing continuous limb position feedback
- Optional EMG surface sensors (selected models) for detecting voluntary muscle activation intent
Control Layer
- Embedded processor running real-time gait state estimation algorithms at high frequency
- Proportional-assistive control adjusting motor torque output based on detected movement intent
- Therapist-facing tablet interface for session setup, assistance level adjustment, and session data review
- Session data logging for progress tracking across multiple therapy sessions
Sensor → Controller → Exoskeleton Output Flow
Sensors detect joint angles, forces, and patient movement intent 20-100 times per second
Control algorithms classify gait phase and calculate required assistance torque for each joint
Motors deliver precisely timed joint torque to support the patient's intended movement
Technical specifications vary by device model. Detailed spec sheets are available upon request.
Backed by Leading Chinese
Exoskeleton Research
Our manufacturing partners have built their product development on foundations of applied research in rehabilitation robotics -- giving their devices a more principled engineering base than typical OEM manufacturers.
Joint Research with Chinese Academy of Sciences
Manufacturing partners have established collaborative research relationships with institutes under the Chinese Academy of Sciences, with joint focus areas including lower-limb biomechanics, exoskeleton gait planning, and human-robot interaction. This academic collaboration informs ongoing product development and validates control algorithm design.
Focus Areas in Rehabilitation Robotics
Key research areas include real-time gait phase estimation, multi-modal sensor fusion for movement intent detection, variable-impedance joint control for natural movement assistance, and clinical validation methodology for rehabilitation exoskeletons.
Research-to-Product Development Pipeline
Algorithm and control approaches validated through research are implemented in product firmware and tested through structured clinical use in partner rehabilitation hospitals before broader deployment. This pipeline ensures product behaviour reflects clinical requirements, not just engineering targets.
Medical-Grade Manufacturing
and Quality Control
All manufacturing partners supplying products through GaitExo operate under formal medical device quality management systems -- ensuring traceability, consistency, and safety across every unit produced.
ISO 13485 Quality System
All manufacturing partners hold or operate under ISO 13485 quality management system certification for medical devices. This covers design control, production processes, supplier management, and post-market surveillance requirements.
Dedicated Assembly & Testing Lines
Products are assembled on dedicated lines with separation from non-medical manufacturing. Each unit undergoes functional testing, joint range verification, motor performance testing, and safety system validation before dispatch.
Component-Level Traceability
Critical components -- including motors, sensors, and structural elements -- are tracked through the assembly process. Batch records and test data are retained to support any post-market quality investigation or regulatory inquiry from importers.
Clinical Use, Safety, and
Patient Experience
These devices are clinical rehabilitation tools designed for supervised use by trained therapists -- not consumer products. Understanding how they are used in practice matters for both distributors and hospital buyers.
Therapist Control Interface -- session setup and assistance level adjustment
Supervised Clinical Use Only
These devices are designed and intended for use under direct supervision of qualified physiotherapists or rehabilitation clinicians. They are not approved for unsupervised home use. All deployment contexts described on this website involve professional clinical oversight.
Patient Selection Criteria
Appropriate patient selection is managed by the clinical team. Typical inclusion considerations include: cognitive ability to follow instructions, body dimensions within device parameters, absence of contraindicated conditions, and rehabilitation goals consistent with gait retraining. Detailed clinical guidelines are provided in product documentation.
Application Scenarios
Devices are used across multiple rehabilitation phases and patient groups: early-phase supported gait retraining (stroke, SCI), transition-phase corridor walking (post-acute neurological), and ongoing ankle/foot management (foot drop, post-surgical). Each device category is designed for a specific phase of the rehabilitation pathway.
Therapist Workload and Patient Throughput
Based on feedback from clinical deployments in China, therapists report being able to manage more training repetitions per session compared to manual-assisted gait therapy, with reduced physical strain over extended deployment periods. These observations are provided as illustrative context, not as clinical outcome claims.
What This Technology Means for
Distributors and Hospitals
- ISO 13485 manufacturing gives you credible quality documentation to present to hospital procurement teams and support any local regulatory pathway
- Research-backed control algorithms differentiate these products from low-cost OEM alternatives -- a meaningful selling point in clinical conversations
- Therapist-facing software interfaces and English documentation reduce the training burden when introducing devices to new hospital customers
- Session data logging supports clinical teams in demonstrating patient progress -- valuable for justifying continued use and reorders
- Adaptive assistance levels allow the same device to serve patients across a broad spectrum of motor ability -- from early-phase complete dependence to late-phase minimal support
- Real-time safety monitoring and automatic joint range limits reduce clinical risk during supervised therapy sessions
- Three-device portfolio (gait trainer + hip assist + ankle/AFO) covers the full rehabilitation pathway -- reducing the need for multiple supplier relationships
- Technical documentation, training materials, and remote Q&A support are provided in English to support your clinical team's onboarding